已收盤 02-06 16:00:00 美东时间
+1.220
+1.03%
今日重点评级关注:康托·菲茨杰拉德:维持Wave Life Sciences Ltd."超配"评级,目标价从34美元升至41美元;Piper Sandler:维持Replimune Group"超配"评级,目标价从13美元升至14美元
02-06 16:52
今日重点评级关注:韦德布什:维持Replimune Group"跑赢大市"评级,目标价从18美元升至19美元;巴克莱:维持CytomX Therapeutics"超配"评级,目标价从8美元升至10美元
02-05 11:28
Stephens & Co. analyst Pooran Sharma reiterates Ingredion (NYSE:INGR) with a Equal-Weight and maintains $120 price target.
02-04 22:24
Ingredion (NYSE:INGR) announced its Q4 earnings on Tuesday, February 3, 2026 at...
02-03 19:48
Ingredion (NYSE:INGR) reported its Q4 earnings results on Tuesday, February 3, ...
02-03 19:32
Ingredion (NYSE:INGR) released its Q4 earnings on Tuesday, February 3, 2026 at ...
02-03 19:24
Ingredion (NYSE:INGR) reported its Q4 earnings results on Tuesday, February 3, ...
02-03 19:18
Companies Reporting Before The Bell • Atkore (NYSE:ATKR) is expected to report ...
02-03 19:11
Ingredion (NYSE:INGR) is looking for FY2026 GAAP EPS of $11.00-$11.80 vs $11.28 analyst estimate..
02-03 19:07
Ingredion (NYSE:INGR) is looking for FY2026 Adj EPS of $11.00-$11.80 vs $11.38 analyst estimate..
02-03 19:06